Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
FDA Label NDC 70771-1620

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 70771-1620). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1620-3

Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 100 mg/150 mg

Rx Only

30 tablets

Mfg Label (4fc42dfb A255 4fb6 8a05 0048c9ccf132 01)

Mfg Label (4fc42dfb A255 4fb6 8a05 0048c9ccf132 01)

NDC 70771-1621-3

Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 133 mg/200 mg

Rx Only

30 tablets

Mfg Label (4fc42dfb A255 4fb6 8a05 0048c9ccf132 02)

Mfg Label (4fc42dfb A255 4fb6 8a05 0048c9ccf132 02)

NDC 70771-1622-3

Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 167 mg/250 mg

Rx Only

30 tablets

Mfg Label (4fc42dfb A255 4fb6 8a05 0048c9ccf132 03)

Mfg Label (4fc42dfb A255 4fb6 8a05 0048c9ccf132 03)

NDC 70771-1709-3

Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 mg/300 mg

Rx Only

30 tablets

Label (4fc42dfb A255 4fb6 8a05 0048c9ccf132 04)

Label (4fc42dfb A255 4fb6 8a05 0048c9ccf132 04)

* Please review the disclaimer below.